1 – 3 of 3
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
(
- Contribution to journal › Article
- 2009
-
Mark
Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells.
(
- Contribution to journal › Article
-
Mark
Ncf1 Provides a Reactive Oxygen Species-Independent Negative Feedback Regulation of TLR9-Induced IL-12p70 in Murine Dendritic Cells
(
- Contribution to journal › Article